28
A focus on migraine, multiple sclerosis and Alzheimer’s disease
Source: Global Burden of Disease Study 2017, Institute for Health Metrics and Evaluation at the University of Washington.
Figure 6: Prevalence of multiple sclerosis in selected countries
(age standardised, both sexes, 2017)
Canada
US
Chile
Mexico
Norway
Israel
Japan
South Korea
Australia
UK
Turkey
Poland
Spain
Hungary
Greece
Denmark
Germany
Italy
France
Czech
Republic
Australia
Canada
Chile
Czech Republic
Denmark
France
Germany
Greece
Hungary
Israel
Italy
Japan
Mexico
Norway
Poland
South Korea
Spain
Turkey
UK
US
14,756
79,723
7,400
5,756
9,130
68,903
94,518
4,192
5,531
3,649
66,953
25,719
11,766
10,358
30,234
11,229
39,421
41,741
97,510
391,627
Country
0.05%
0.17%
0.03%
0.04%
0.12%
0.08%
0.08%
0.03%
0.04%
0.04%
0.08% 0.01%
0.01%
0.15%
0.06%
0.06% 0.02%
0.05%
0.12%
0.10%
Prevalent cases,
all ages
Source: Global Burden of Disease Study 2017, Institute for Health Metrics and Evaluation at the University of Washington.
Canada
US
Chile
Mexico
Norway
Israel
Japan
South Korea
Australia
UK
Turkey
Poland
Spain
Hungary
Greece
Denmark
Germany
Italy
France
Czech
Republic
Australia
Canada
Chile
Czech Republic
Denmark
France
Germany
Greece
Hungary
Israel
Italy
Japan
Mexico
Norway
Poland
South Korea
Spain
Turkey
UK
US
4,522,390
7,617,936
2,763,961
2,071,481
947,630
11,338,200
16,782,608
2,747,884
1,936,989
1,874,030
16,720,603
17,553,973
20,900,479
1,266,712
7,670,938
9,705,436
12,763,776
16,138,552
13,757,472
68,486,546
Country
18.10%
20.13%
14.32%
17.84%
15.77%
16.84%
19.11%
25.28%
17.95%
21.30%
26.34% 13.51%
16.06%
22.84%
17.92%
25.80% 16.55%
18.64%
19.73%
20.19%
Prevalent cases,
all ages
Figure 7: Prevalence of migraine in selected countries
(age standardised, both sexes, 2017)
